Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kari Furu

Showing results (91-100 of 138) with videos related to

Pageof 14
Sort By:
European Child & Adolescent Psychiatry|July 13, 2022
Trends in use of attention deficit hyperactivity disorder medication among children and adolescents in Scandinavia in 2010-2020Anne Mette Skov Sørensen, Rikke Wesselhöeft, Jacob Harbo Andersen, et al.
Pharmacoepidemiology and Drug Safety|November 4, 2025
EpiCore-A Common Data Model for Pharmacoepidemiological Studies in Denmark, Norway, and SwedenPeter Bjødstrup Jensen, Jacob H Andersen, Martin Thomsen Ernst, et al.
The British Journal of Psychiatry : the Journal of Mental Science|November 7, 2025
Attention-deficit hyperactivity disorder medication use in pregnancy and risk of miscarriageChaitra Srinivas, Øystein Karlstad, Hein Stigum, et al.
European Child & Adolescent Psychiatry|June 29, 2026
Incidence of ADHD diagnoses and medication initiation among children and adolescents in Norway from 2016-2024Saima Orangzeb, Ingeborg Hartz, Inger Johanne Bakken, et al.
Statistics in Medicine|March 5, 2019
Adjusting for unmeasured confounding using validation data: Simplified two-stage calibration for survival and dichotomous outcomesVidar Hjellvik, Marie L De Bruin, Sven O Samuelsen, et al.
JAMA|January 3, 2013
Selective serotonin reuptake inhibitors during pregnancy and risk of stillbirth and infant mortalityOlof Stephansson, Helle Kieler, Bengt Haglund, et al.
Diabetes, Obesity & Metabolism|February 29, 2024
Pharmacological treatment of obesity in adults in Norway 2004-2022Paz Lopez-Doriga Ruiz, Øystein Karlstad, Kjersti Nøkleby, et al.
BMJ (Clinical Research Ed.)|January 14, 2012
Selective serotonin reuptake inhibitors during pregnancy and risk of persistent pulmonary hypertension in the newborn: population based cohort study from the five Nordic countriesHelle Kieler, Miia Artama, Anders Engeland, et al.
Diabetes, Obesity & Metabolism|May 5, 2026
Clinical Characteristics of Users of Weight Loss Drugs: Population-Based Case-Control StudyInger Johanne Bakken, Paz Lopez-Doriga Ruiz, Kari Furu, et al.
BMJ (Clinical Research Ed.)|April 19, 2015
Selective serotonin reuptake inhibitors and venlafaxine in early pregnancy and risk of birth defects: population based cohort study and sibling designKari Furu, Helle Kieler, Bengt Haglund, et al.
Pageof 14

Showing results (91-100 of 138) with videos related to

Sort By:
Pageof 14
European Child & Adolescent Psychiatry|July 13, 2022
Trends in use of attention deficit hyperactivity disorder medication among children and adolescents in Scandinavia in 2010-2020Anne Mette Skov Sørensen, Rikke Wesselhöeft, Jacob Harbo Andersen, et al.
Pharmacoepidemiology and Drug Safety|November 4, 2025
EpiCore-A Common Data Model for Pharmacoepidemiological Studies in Denmark, Norway, and SwedenPeter Bjødstrup Jensen, Jacob H Andersen, Martin Thomsen Ernst, et al.
The British Journal of Psychiatry : the Journal of Mental Science|November 7, 2025
Attention-deficit hyperactivity disorder medication use in pregnancy and risk of miscarriageChaitra Srinivas, Øystein Karlstad, Hein Stigum, et al.
European Child & Adolescent Psychiatry|June 29, 2026
Incidence of ADHD diagnoses and medication initiation among children and adolescents in Norway from 2016-2024Saima Orangzeb, Ingeborg Hartz, Inger Johanne Bakken, et al.
Statistics in Medicine|March 5, 2019
Adjusting for unmeasured confounding using validation data: Simplified two-stage calibration for survival and dichotomous outcomesVidar Hjellvik, Marie L De Bruin, Sven O Samuelsen, et al.
JAMA|January 3, 2013
Selective serotonin reuptake inhibitors during pregnancy and risk of stillbirth and infant mortalityOlof Stephansson, Helle Kieler, Bengt Haglund, et al.
Diabetes, Obesity & Metabolism|February 29, 2024
Pharmacological treatment of obesity in adults in Norway 2004-2022Paz Lopez-Doriga Ruiz, Øystein Karlstad, Kjersti Nøkleby, et al.
BMJ (Clinical Research Ed.)|January 14, 2012
Selective serotonin reuptake inhibitors during pregnancy and risk of persistent pulmonary hypertension in the newborn: population based cohort study from the five Nordic countriesHelle Kieler, Miia Artama, Anders Engeland, et al.
Diabetes, Obesity & Metabolism|May 5, 2026
Clinical Characteristics of Users of Weight Loss Drugs: Population-Based Case-Control StudyInger Johanne Bakken, Paz Lopez-Doriga Ruiz, Kari Furu, et al.
BMJ (Clinical Research Ed.)|April 19, 2015
Selective serotonin reuptake inhibitors and venlafaxine in early pregnancy and risk of birth defects: population based cohort study and sibling designKari Furu, Helle Kieler, Bengt Haglund, et al.
Pageof 14